XTX Topco Ltd

Position in OCUL — Ocular Therapeutix, Inc

CIK 1828301 LONDON, X0

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$996,445

-$2,350,763 QoQ

Shares Held

101,471

-74.3% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#105

of 257 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $412,987,661 across 381 Biotechnology names. OCUL ranks #120 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$996,445	101,471	-74.3%	Shares	Defined	2026-08-14
2026-03-31	$3,347,208	395,184	+705.3%	Shares	Defined	2026-05-15
2025-12-31	$595,746	49,073	+42.5%	Shares	Defined	2026-02-17
2025-09-30	$402,521	34,433	+52.3%	Shares	Defined	2025-11-14
2025-03-31	$165,694	22,605	+95.0%	Shares	Defined	2025-05-08
2024-12-31	$99,004	11,593	-58.5%	Shares	Defined	2025-02-13
2023-12-31	$124,621	27,942	-88.2%	Shares	Defined	2024-02-13
2022-12-31	$665,551	236,851	+353.2%	Shares	Defined	2023-02-14
2022-09-30	$216,903	52,266	+131.6%	Shares	Defined	2022-11-14
2022-06-30	$90,723	22,568	-36.9%	Shares	Defined	2022-08-15
2022-03-31	$177,046	35,767	+193.5%	Shares	Defined	2022-05-13
2021-12-31	$84,929	12,185	-47.3%	Shares	Defined	2022-02-11
2021-06-30	$327,855	23,121	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.